Article Details

J&J coordinating with FDA on US pause of Varipulse due to safety risks | MedTech Dive

Retrieved on: 2025-01-22 17:37:26

Tags for this article:

Click the tags to see associated articles and topics

J&J coordinating with FDA on US pause of Varipulse due to safety risks | MedTech Dive. View article details on hiswai:

Summary

The article discusses Johnson & Johnson's pause on its Varipulse device due to safety concerns, highlighting the Medtech industry's sales growth and market competition. COVID-19 impacts are deemed resolved, with procedures back to pre-pandemic levels.

Article found on: www.medtechdive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up